News at CenExel

April 3, 2022

Cultivating Retention in Schizophrenia and Schizoaffective Disorder Studies: Patient Preferences for Clinical Trial Methodologies and COVID19 Mitigations

CenExel is proud to highlight the poster presented at the Schizophrenia International Research Society (SIRS) Annual Scientific Meeting, April 2022, Florence Italy. ABSTRACT Background: Clinical...

November 3, 2021

FURTHERING OUR UNDERSTANDING OF PARTICIPANT RETENTION: AN ANALYSIS OF RESEARCH SITES’ STUDY DATA AND METHODOLOGICAL CORRELATES

CenExel is proud to highlight the poster presented at the Annual CNS Summit, November 2021, Boston, MA. ABSTRACT Introduction: Psychiatric clinical trials are beset by...

June 3, 2021

Attending to the Patient with Major Depression: Preferences for Clinical Trial Methodologies and COVID19 Mitigations

CenExel is proud to highlight the poster presented at the American Society of Clinical Psychopharmacology (ASCP) Annual Scientific Meeting, June 2021, Virtual Meeting. ABSTRACT Introduction: The continued...

April 3, 2021

Giving Voice to Patients With Schizophrenia or Schizoaffective Disorder: Preferences for Clinical Trial Methodologies and COVID19 Mitigations

CenExel is proud to highlight the poster presented at the International Society for CNS Clinical Trials and Methodology (ISCTM) Annual Scientific Meeting, April 2021, Virtual Meeting. ABSTRACT...

News at CenExel

Cultivating Retention in Schizophrenia and Schizoaffective Disorder Studies: Patient Preferences for Clinical Trial Methodologies and COVID19 Mitigations

FURTHERING OUR UNDERSTANDING OF PARTICIPANT RETENTION:​ AN ANALYSIS OF RESEARCH SITES’ STUDY DATA AND METHODOLOGICAL CORRELATES​

Attending to the Patient with Major Depression:​ Preferences for Clinical Trial Methodologies and COVID19 Mitigations​

Giving Voice to Patients With Schizophrenia or Schizoaffective Disorder:​ Preferences for Clinical Trial Methodologies and COVID19 Mitigations​

Cultivating Retention in Schizophrenia and Schizoaffective Disorder Studies: Patient Preferences for Clinical Trial Methodologies and COVID19 Mitigations

FURTHERING OUR UNDERSTANDING OF PARTICIPANT RETENTION: AN ANALYSIS OF RESEARCH SITES’ STUDY DATA AND METHODOLOGICAL CORRELATES

Attending to the Patient with Major Depression: Preferences for Clinical Trial Methodologies and COVID19 Mitigations

Giving Voice to Patients With Schizophrenia or Schizoaffective Disorder: Preferences for Clinical Trial Methodologies and COVID19 Mitigations